Menu

News

« » View all News

CPTR 2014 New Drug Development Workshop Report Day 2

Day Two: September 25, 2014

EVALUATING THE IMPACT OF ENGAGEMENT ON TB DRUG DEVELOPMENT
DAY TWO: SEPTEMBER 25, 2014

Objective: Discuss the level of engagement needed for the future TB drug development.

EMERGING ISSUES IN THE REGULATORY SCIENCE OF TB DRUG REGIMEN DEVELOPMENT

Objective: Discuss the impact of emerging issues in regards to the regulatory sciences.
Moderator: Matt Lumpik, Bill & Melinda Gates Foundation
See Matt Lumpik’s video.

CLOSING REMARKS

Presenter: Uvistra Naidoo, Physician, South Africa
Uvistra Naidoo closed the conference with the inspiring story of his experience as a TB survivor. During his battle with TB, he underwent more than 3 years of treatment – taking more than 20 tablets of treatment a day, and suffering severe side effects. He challenged the group to collaborate and to work together to reverse pessimism and inspire hope in the fight against TB.
See Uvistra Naidoo’s video.

ADJOURNMENT

Presenter: Jan Gheuens, Bill & Melinda Gates Foundation
Jan Gheuens noted the evolution and maturation of CPTR in a number of areas, as well as its expanding scope. He summarized several themes of the conference and noted a number of current challenges for the community in their efforts to fight TB.
See Jan Ghuens’ video.

« » View all News